Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News VBI Vaccines Inc VBIVQ

Healthcare Biotechnology

VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The... see more

Add To Watchlist

Recent & Breaking News (PINL:VBIVQ)

VBI Vaccines to Present at the Bloom Burton Healthcare Investor Conference

GlobeNewswire April 28, 2016

VBI Vaccines to Present at the World Vaccine Congress Washington

GlobeNewswire March 29, 2016

Best Stocks to Buy Right Now for March 2016, If You So Choose

Accesswire March 8, 2016

VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

GlobeNewswire March 7, 2016

VBI Vaccines to Present at the ROTH Conference

GlobeNewswire March 3, 2016

Stocks That Demand Your Attention and Consideration Right Now

Accesswire February 29, 2016

3 Stocks That Should be in Your Portfolio Today

Accesswire February 26, 2016

3 Biotech Stocks to Consider Buying Right Now

Accesswire February 25, 2016

GlaxoSmithKline Partners With VBI Vaccines, SciVac To Eliminate Cold Chain

Press Releases February 17, 2016

Biotech Stocks to Buy in a Down Market

Accesswire February 10, 2016

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability

GlobeNewswire February 9, 2016

VBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness

GlobeNewswire February 4, 2016

VBI Vaccines to Present at the BIO CEO & Investor Conference

GlobeNewswire January 26, 2016

VBI Vaccines to Present at the Noble Financial Emerging Growth Investor Conference

GlobeNewswire January 18, 2016

What are the Charts Conveying - Research on Sunshine Bancorp, Rave Restaurant Group, VBI Vaccines, and S&W Seed

Accesswire December 4, 2015

VBI Vaccines to Present at the LD Micro Conference

GlobeNewswire November 25, 2015

VBI Vaccines Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology

GlobeNewswire November 20, 2015

VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe

GlobeNewswire November 6, 2015

VBI Vaccines and SciVac Therapeutics To Live Webcast Joint Conference Call For Shareholders to Discuss Proposed Merger

GlobeNewswire November 4, 2015

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of VBI Vaccines Inc. of an Investigation Concerning the Fairness of the Sale of the Company to SciVac Therapeutics Inc. -- VBIV

Business Wire October 30, 2015